Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,926,700 | 1,476,000 | 1,031,600 | 718,500 | 573,300 |
| Cost of Goods | 646,600 | 544,500 | 367,700 | 226,400 | 194,900 |
| Gross Profit | 1,280,100 | 931,500 | 663,900 | 492,100 | 378,400 |
| Operating Expenses | 981,200 | 789,700 | 850,900 | 535,000 | 443,200 |
| Operating Income | 299,500 | 142,300 | -186,300 | -42,500 | -63,900 |
| Interest Expense | 17,700 | 60,300 | 22,700 | 12,800 | 700 |
| Other Income | 16,100 | 22,200 | 82,500 | 6,700 | -300 |
| Pre-tax Income | 297,900 | 104,200 | -126,500 | -48,600 | -64,900 |
| Income Tax | -251,800 | 3,100 | 600 | 1,600 | 700 |
| Net Income Continuous | 549,700 | 101,100 | -127,100 | -50,200 | -65,600 |
| Net Income | $549,700 | $101,100 | $-127,100 | $-50,200 | $-65,600 |
| EPS Basic Total Ops | 1.46 | 0.28 | -0.36 | -0.15 | -0.20 |
| EPS Basic Continuous Ops | 1.46 | 0.28 | -0.36 | -0.15 | -0.20 |
| EPS Diluted Total Ops | 1.33 | 0.28 | -0.36 | -0.15 | -0.20 |
| EPS Diluted Continuous Ops | 1.31 | 0.27 | -0.36 | -0.15 | -0.20 |
| EPS Diluted Before Non-Recurring Items | 0.78 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $366,600 | $191,000 | $-157,200 | $-26,400 | $-48,900 |